Endogenius Intelligence from within

Our solutions

Built for decisions — not for chat.

Endogenius™ is decision technology for live environments. Below: why we are not another generative AI product, then the four domains we serve.

Why we are different

Not another generative AI.

Generative AI is strong at drafting text and summarizing documents. Deep learning is strong at spotting patterns in large, stable datasets. Both struggle when the world moves — when today’s “normal” is not yesterday’s, and when a fluent answer is not the same as a safe decision.

Endogenius™ is built for that gap. We focus on what to do next under uncertainty: sensing when confidence should drop, respecting domain rules, and keeping a trail you can review. We use learning where it helps. We do not pretend a language model is a complete decision system.

  • Designed for changing conditions, not only fixed benchmarks
  • Cautious when unsure — not confidently wrong
  • Explainable enough for partners and operators to defend

10-second LinkedIn explainer — competitive radar vs LLM / ML stacks.

Domains

Four places we put this to work.

Same decision philosophy. Different products and operating rules for each field.

Healthcare

Our objective is to help move care from generalised medicine — one protocol for many — toward personalised medicine: decisions that fit this patient, this disease context, and this safety profile, when evidence is partial and conditions keep changing.

Older woman consulting with a pharmacist about medications
Geriatric pharmacology Personalised medication choices when age, comorbidity, and drug interactions stack up. Photo: Rhoda Baer / National Cancer Institute (public domain via Wikimedia Commons)
Clinician examining a child with a stethoscope during a physical exam
Rare disease Structured reasoning over sparse orphan-disease evidence — labels and catalogues before free text. Photo: Ragesoss / Wikimedia Commons (CC BY-SA 3.0)
Doctor consulting with a patient in a clinical oncology setting
Precision oncology Tumour- and pathway-aware support so therapy choices follow the person’s biology, not a generic playbook alone. Photo: National Cancer Institute (public domain via Wikimedia Commons)

Financial markets

Decision support for portfolios and desks that face regime shifts, noise, and the need to act — or wait — with discipline.

Endogenius trademark AEM research wealth curve from 2008 to 2026 year-to-date versus SPY on a log scale
Wealth indicator (log scale) — research backtest, Soft DD stack, 2 Jan 2008 → 22 May 2026 YTD.

Example

$1,000 invested at the start of the sample would have grown to about $859,000 by 22 May 2026 YTD (exact: $858,933).

The same $1,000 in SPY over the identical dates would have been about $7,180.

  • CAGR 44.4%
  • Sharpe 2.78
  • Max drawdown −12.1%
  • Multiple ~859×

Research simulation — not live trading. Past simulated results do not guarantee future performance.

  • Adaptive equity decision systems Tools that read changing market conditions and help size or stand down with an audit trail.
  • Partner desk overlays Technology that sits with your process — you keep the client book.

Cybersecurity

Help for security teams when traffic and threats do not look like last month’s training set.

Public suite overview — detector names generalised (Alg.1–Alg.6); IDS feeds labelled IDS.1.
Product clip (~20s), public cut — Alg.1–Alg.6 and IDS.1 throughout every scene.
  • Adaptive detection & triage Signal fusion and cautious action when uncertainty rises — fewer false comforts.
  • SOC decision support Operator-facing recommendations that respect policy, not chatbots improvising policy.

Autonomy & field systems

Decision layers for platforms that must keep operating when links degrade and the environment will not wait.

20-second dispersed fleet UAV demo — GPS-denied or C2 control attempt · numbered mission steps · pilot takeover (TRL 5–6).

  • Contested & degraded operations Onboard logic that stays useful when the world — or the network — is unreliable.
  • Mission decision support Clearer next-step guidance for operators under time pressure.